
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Endocrinol. , 13 March 2025
Sec. Obesity
Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1580595
This article is a correction to:
Is choline kinase alpha a drug target for obesity?
A Corrigendum on
Is choline kinase alpha a drug target for obesity?
By Lacal JC, Ibrahim SA and Zimmerman T (2024) Front. Endocrinol. 15:1492753. doi: 10.3389/fendo.2024.1492753
In the published article, there was a mistake in the Funding statement. The authors mistakenly stated that no financial support was received for this research.
The correct statement is “The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was supported by Grant PID2020-116165RB-C21 funded by MCIN/AEI/10.13039/501100011033 to JL.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: choline, choline kinase, thermogenesis, adipogenesis, obesity
Citation: Lacal JC, Ibrahim SA and Zimmerman T (2025) Corrigendum: Is choline kinase alpha a drug target for obesity? Front. Endocrinol. 16:1580595. doi: 10.3389/fendo.2025.1580595
Received: 20 February 2025; Accepted: 28 February 2025;
Published: 13 March 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Lacal, Ibrahim and Zimmerman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Juan Carlos Lacal, amNsYWNhbEBpaWIudWFtLmVz; Tahl Zimmerman, dHppbW1lcm1AaGlnaHBvaW50LmVkdQ==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.